Skip to main content
Equibles

Schonfeld Strategic Advisors LLC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1665241 NEW YORK, NY
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,199,799
+$118,463 QoQ
Shares Held
66,804
-14.1% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#89
of 207 holders
Holding Since
Sep 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $64,099,635 across 21 Drug Manufacturers - Specialty & Generic names. AMLX ranks #12 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HROW
Harrow, Inc.
 319,625 $13,574,473
2 ALKS
Alkermes plc.
 195,174 $10,227,117
3 BCRX
Biocryst Pharmaceuticals Inc
 710,816 $7,108,160
4 INDV
Indivior Pharmaceuticals, Inc.
 130,982 $5,374,191
5 AMRX
Amneal Pharmaceuticals, Inc.
 305,991 $5,296,704
6 ZTS
Zoetis Inc.
 63,752 $4,581,218
7 ANIP
Ani Pharmaceuticals Inc
 41,217 $3,411,943
8 HLN
Haleon plc
 363,872 $3,394,925

All Filings in AMLX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,199,799 66,804
2026-03-31 $1,081,336 77,794
2025-12-31 $254,308 21,052
2025-09-30 $593,026 43,637
2025-06-30 $4,143,699 646,443
2025-03-31 $414,675 117,140
2024-12-31 $733,059 193,931
2024-09-30 $539,229 166,429
2024-06-30 $41,040 21,600
2023-09-30 $2,518,046 137,523
2023-06-30 $4,538,004 210,385
2023-03-31 $8,362,046 285,005
2022-12-31 $4,135,591 111,924
2022-09-30 $9,168,455 325,700